Im
ImmunoGen (AbbVie)
Waltham MAFounded 1981600 employees
Private CapbiotechAcquiredOncology
Platform: Mirvetuximab ADC
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Miriinavolisib | IMM-7408 | Phase 3 | 3 | Nectin-4 | MDDPBC | ||
| IMM-7144 | IMM-7144 | Approved | 2 | PI3Kα | Bladder CaEoE | ||
| IMM-8177 | IMM-8177 | Phase 1 | 1 | Menin | RSV | ||
| IMM-7074 | IMM-7074 | Phase 1/2 | 2 | WRN | ALLDravet |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (5)